Regulation of the glutamate transporters by JAK2

Cellular Physiology and Biochemistry

Volumn 28, Issue 4, 2011, Pages 693-702

  Hosseinzadeh, Zohreh ^a   Bhavsar, Shefalee K ^a   Sopjani, Mentor ^a,b   Alesutan, Ioana ^a   Saxena, Ambrish ^a   Dërmaku Sopjani, Miribane ^a,b   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF PRISHTINA   (Serbia)

Author keywords

Astrocytes; Erythropoietin; Excitatory amino acid transporter; Leptin; Neuroexcitability; Neurotransmission

Indexed keywords

BREFELDIN A; DACTINOMYCIN; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CELL SURFACE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GAIN OF FUNCTION MUTATION; GENE INSERTION; HUMAN; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; NONHUMAN; OOCYTE; OOCYTE RETRIEVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SLOW INWARD CURRENT; UPREGULATION; XENOPUS LAEVIS;

EID: 83755195377     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335763     Document Type: Article

References (94)

1. Morris DL, Rui L: Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009;297:E1247-E1259.
2. Diano S, Horvath TL: Anticonvulsant effects of leptin in epilepsy. J Clin Invest 2008;118:26-28.
3. Xu L, Rensing N, Yang XF, Zhang HX, Thio LL, Rothman SM, Weisenfeld AE, Wong M, Yamada KA: Leptin inhibits 4-aminopyridine-and pentylenetetrazoleinduced seizures and AMPAR-mediated synaptic transmission in rodents. J Clin Invest 2008;118:272-280.
4. Dawson TM: Preconditioning-mediated neuroprotection through erythropoietin? Lancet 2002;359:96-97. (Pubitemid 34112534)
5. Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M: Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 2001;276:39469-39475.
6. Won YJ, Yoo JY, Lee JH, Hwang SJ, Kim D, Hong HN: Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures. Brain Res 2007;1154:31-39. (Pubitemid 46856347)
7. Estrada Sanchez AM, Mejia-Toiber J, Massieu L: Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Arch Med Res 2008;39:265-276. (Pubitemid 351221151)
8. Markowitz AJ, White MG, Kolson DL, Jordan-Sciutto KL: Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration. Cellscience 2007;4:111-146.
9. Beart PM, O'shea RD: Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 2007;150:5-17. (Pubitemid 46094664)
10. Foran E, Trotti D: Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal 2009;11:1587-1602.
11. Sheldon AL, Robinson MB: The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 2007;51:333-355. (Pubitemid 47503456)
12. Versen-Hoynck F, Rajakumar A, Parrott MS, Powers RW: Leptin affects system A amino acid transport activity in the human placenta: evidence for STAT3 dependent mechanisms. Placenta 2009;30:361-367.
13. Boehmer C, Henke G, Schniepp R, Palmada M, Rothstein JD, Broer S, Lang F: Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid-inducible kinase isoforms SGK1/3 and protein kinase B. J Neurochem 2003;86:1181-1188. (Pubitemid 37022194)
14. Gehring EM, Zurn A, Klaus F, Laufer J, Sopjani M, Lindner R, Strutz-Seebohm N, Tavare JM, Boehmer C, Palmada M, Lang UE, Seebohm G, Lang F: Regulation of the glutamate transporter EAAT2 by PIKfyve. Cell Physiol Biochem 2009;24:361-368.
15. Shigeri Y, Shimamoto K, Yasuda-Kamatani Y, Seal RP, Yumoto N, Nakajima T, Amara SG: Effects of threobeta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5). J Neurochem 2001;79:297-302. (Pubitemid 32988945)
16. Sopjani M, Alesutan I, Dermaku-Sopjani M, Fraser S, Kemp BE, Foller M, Lang F: Down-regulation of Na+-coupled glutamate transporter EAAT3 and EAAT4 by AMP-activated protein kinase. J Neurochem 2010;113:1426-1435.
17. Dowd LA, Robinson MB: Rapid stimulation of EAAC1-mediated Na+-dependent L-glutamate transport activity in C6 glioma cells by phorbol ester. J Neurochem 1996;67:508-516. (Pubitemid 26255643)
18. Alesutan IS, Ureche ON, Laufer J, Klaus F, Zurn A, Lindner R, Strutz-Seebohm N, Tavare JM, Boehmer C, Palmada M, Lang UE, Seebohm G, Lang F: Regulation of the glutamate transporter EAAT4 by PIKfyve. Cell Physiol Biochem 2010;25:187-194.
19. Cheng C, Glover G, Banker G, Amara SG: A novel sorting motif in the glutamate transporter excitatory amino acid transporter 3 directs its targeting in Madin-Darby canine kidney cells and hippocampal neurons. J Neurosci 2002;22:10643-10652. (Pubitemid 36005138)
20. Feng J, Witthuhn BA, Matsuda T, Kohlhuber F, Kerr IM, Ihle JN: Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol Cell Biol 1997;17:2497-2501. (Pubitemid 27175130)
21. Mahfouz RA, Hoteit R, Salem Z, Bazarbachi A, Mugharbel A, Farhat F, Ziyadeh A, Ibrahim A, Taher A JAK2 V617F Gene Mutation in the Laboratory Work-Up of Myeloproliferative Disorders: Experience of a Major Referral Center in Lebanon Genet Test Mol Biomarkers 2011;
22. Mohamed MR, Alesutan I, Foller M, Sopjani M, Bress A, Baur M, Salama RH, Bakr MS, Mohamed MA, Blin N, Lang F, Pfister M: Functional analysis of a novel I71N mutation in the GJB2 gene among Southern Egyptians causing autosomal recessive hearing loss. Cell Physiol Biochem 2010;26:959-966.
23. Bohmer C, Sopjani M, Klaus F, Lindner R, Laufer J, Jeyaraj S, Lang F, Palmada M: The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell Physiol Biochem 2010;25:723-732.
24. Eckey K, Strutz-Seebohm N, Katz G, Fuhrmann G, Henrion U, Pott L, Linke WA, Arad M, Lang F, Seebohm G: Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT). Cell Physiol Biochem 2010;26:503-512.
25. Laufer J, Boehmer C, Jeyaraj S, Knuwer M, Klaus F, Lindner R, Palmada M, Lang F: The C-terminal PDZ-binding motif in the Kv1.5 potassium channel governs its modulation by the Na+/H+ exchanger regulatory factor 2. Cell Physiol Biochem 2009;23:25-36.
26. Henrion U, Strutz-Seebohm N, Duszenko M, Lang F, Seebohm G: Long QT syndrome-associated mutations in the voltage sensor of I(Ks) channels. Cell Physiol Biochem 2009;24:11-16.
27. Rexhepaj R, Dermaku-Sopjani M, Gehring EM, Sopjani M, Kempe DS, Foller M, Lang F: Stimulation of electrogenic glucose transport by glycogen synthase kinase 3. Cell Physiol Biochem 2010;26:641-646.
28. Amara SG, Fontana AC: Excitatory amino acid transporters: keeping up with glutamate. Neurochem Int 2002;41:313-318.
29. Berger UV, Hediger MA: Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization. Anat Embryol (Berl) 1998;198:13-30. (Pubitemid 28333913)
30. Cholet N, Pellerin L, Magistretti PJ, Hamel E: Similar perisynaptic glial localization for the Na+,K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex. Cereb Cortex 2002;12:515-525. (Pubitemid 34578666)
31. Sandhu JK, Sikorska M, Walker PR: Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. J Neurosci Res 2002;68:604-614. (Pubitemid 34575626)
32. Ullensvang K, Lehre KP, Storm-Mathisen J, Danbolt NC: Differential developmental expression of the two rat brain glutamate transporter proteins GLAST and GLT. Eur J Neurosci 1997;9:1646-1655. (Pubitemid 27348323)
33. Domercq M, Sanchez-Gomez MV, Areso P, Matute C: Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur J Neurosci 1999;11:2226-2236. (Pubitemid 29292316)
34. Gaillet S, Plachez C, Malaval F, Bezine MF, Recasens M: Transient increase in the high affinity [3H]-L-glutamate uptake activity during in vitro development of hippocampal neurons in culture. Neurochem Int 2001;38:293-301. (Pubitemid 32012989)
35. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW: Localization of neuronal and glial glutamate transporters. Neuron 1994;13:713-725. (Pubitemid 24300175)
36. Barnett NL, Pow DV: Antisense knockdown of GLAST, a glial glutamate transporter, compromises retinal function. Invest Ophthalmol Vis Sci 2000;41:585-591. (Pubitemid 30080465)
37. Derouiche A, Rauen T: Coincidence of Lglutamate/ L-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: evidence for coupling of GLAST and GS in transmitter clearance. J Neurosci Res 1995;42:131-143.
38. Lawton DM, Furness DN, Lindemann B, Hackney CM: Localization of the glutamate-aspartate transporter, GLAST, in rat taste buds. Eur J Neurosci 2000;12:3163-3171.
39. Furness DN, Lehre KP: Immunocytochemical localization of a high-affinity glutamate-aspartate transporter, GLAST, in the rat and guinea-pig cochlea. Eur J Neurosci 1997;9:1961-1969. (Pubitemid 27429915)
40. Li HS, Niedzielski AS, Beisel KW, Hiel H, Wenthold RJ, Morley BJ: Identification of a glutamate/aspartate transporter in the rat cochlea. Hear Res 1994;78:235-242.
41. Takumi Y, Matsubara A, Danbolt NC, Laake JH, Storm-Mathisen J, Usami S, Shinkawa H, Ottersen OP: Discrete cellular and subcellular localization of glutamine synthetase and the glutamate transporter GLAST in the rat vestibular end organ. Neuroscience 1997;79:1137-1144. (Pubitemid 27293763)
42. Lee JA, Long Z, Nimura N, Iwatsubo T, Imai K, Homma H: Localization, transport, and uptake of D-aspartate in the rat adrenal and pituitary glands. Arch Biochem Biophys 2001;385:242-249. (Pubitemid 32989280)
43. Redecker P, Pabst H: Immunohistochemical study of the glutamate transporter proteins GLT-1 and GLAST in rat and gerbil pineal gland. J Pineal Res 2000;28:179-184. (Pubitemid 30162450)
44. Gray C, Marie H, Arora M, Tanaka K, Boyde A, Jones S, Attwell D: Glutamate does not play a major role in controlling bone growth. J Bone Miner Res 2001;16:742-749. (Pubitemid 32230603)
45. Mason DJ, Suva LJ, Genever PG, Patton AJ, Steuckle S, Hillam RA, Skerry TM: Mechanically regulated expression of a neural glutamate transporter in bone: A role for excitatory amino acids as osteotropic agents? Bone 1997;20:199-205. (Pubitemid 27141830)
46. Milton ID, Banner SJ, Ince PG, Piggott NH, Fray AE, Thatcher N, Horne CH, Shaw PJ: Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study. Brain Res Mol Brain Res 1997;52:17-31. (Pubitemid 27522162)
47. Lehre KP, Danbolt NC: The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J Neurosci 1998;18:8751-8757. (Pubitemid 28491741)
48. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes HM, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB: Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005;433:73-77. (Pubitemid 40101145)
49. Gibb SL, Boston-Howes W, Lavina ZS, Gustincich S, Brown RH, Jr., Pasinelli P, Trotti D: A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis. J Biol Chem 2007;282:32480-32490. (Pubitemid 350106448)
50. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675-686. (Pubitemid 26103145)
51. Collin M, Backberg M, Ovesjo ML, Fisone G, Edwards RH, Fujiyama F, Meister B: Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. Eur J Neurosci 2003;18:1265-1278. (Pubitemid 37115045)
52. Furuta A, Martin LJ, Lin CL, Dykes-Hoberg M, Rothstein JD: Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4. Neuroscience 1997;81:1031-1042. (Pubitemid 27421767)
53. Furuta A, Takashima S, Yokoo H, Rothstein JD, Wada K, Iwaki T: Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly. Brain Res Dev Brain Res 2005;155:155-164. (Pubitemid 40404069)
54. Huang YH, Dykes-Hoberg M, Tanaka K, Rothstein JD, Bergles DE: Climbing fiber activation of EAAT4 transporters and kainate receptors in cerebellar Purkinje cells. J Neurosci 2004;24:103-111. (Pubitemid 38181675)
55. Nieoullon A, Canolle B, Masmejean F, Guillet B, Pisano P, Lortet S: The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse? J Neurochem 2006;98:1007-1018. (Pubitemid 44127778)
56. Schmitt A, Zink M, Petroianu G, May B, Braus DF, Henn FA: Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain. Neurosci Lett 2003;347:81-84. (Pubitemid 36836221)
57. Shashidharan P, Huntley GW, Murray JM, Buku A, Moran T, Walsh MJ, Morrison JH, Plaitakis A: Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody. Brain Res 1997;773:139-148. (Pubitemid 27521118)
58. Schniepp R, Kohler K, Ladewig T, Guenther E, Henke G, Palmada M, Boehmer C, Rothstein JD, Broer S, Lang F: Retinal colocalization and in vitro interaction of the glutamate transporter EAAT3 and the serum-and glucocorticoid-inducible kinase SGK1 [correction]. Invest Ophthalmol Vis Sci 2004;45:1442-1449. (Pubitemid 38859323)
59. Miralles VJ, Martinez-Lopez I, Zaragoza R, Borras E, Garcia C, Pallardo FV, Vina JR: Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress. Brain Res 2001;922:21-29. (Pubitemid 33152841)
60. van Landeghem FK, Weiss T, von Deimling A: Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS. Regul Pept 2007;142:52-59. (Pubitemid 46766609)
61. Rainesalo S, Keranen T, Saransaari P, Honkaniemi J: GABA and glutamate transporters are expressed in human platelets. Brain Res Mol Brain Res 2005;141:161-165. (Pubitemid 41608697)
62. Zoia C, Cogliati T, Tagliabue E, Cavaletti G, Sala G, Galimberti G, Rivolta I, Rossi V, Frattola L, Ferrarese C: Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol Aging 2004;25:149-157. (Pubitemid 38121688)
63. King N, Lin H, McGivan JD, Suleiman MS: Aspartate transporter expression and activity in hypertrophic rat heart and ischaemia-reperfusion injury. J Physiol 2004;556:849-858. (Pubitemid 38660318)
64. Gloy J, Reitinger S, Fischer KG, Schreiber R, Boucherot A, Kunzelmann K, Mundel P, Pavenstadt H: Amino acid transport in podocytes. Am J Physiol Renal Physiol 2000;278:F999-F1005. (Pubitemid 30441366)
65. Cooper TG, Wagenfeld A, Cornwall GA, Hsia N, Chu ST, Orgebin-Crist MC, Drevet J, Vernet P, Avram C, Nieschlag E, Yeung CH: Gene and protein expression in the epididymis of infertile c-ros receptor tyrosine kinase-deficient mice. Biol Reprod 2003;69:1750-1762. (Pubitemid 37362863)
66. Matthews JC, Beveridge MJ, Dialynas E, Bartke A, Kilberg MS, Novak DA: Placental anionic and cationic amino acid transporter expression in growth hormone overexpressing and null IGF-II or null IGFI receptor mice. Placenta 1999;20:639-650. (Pubitemid 29479009)
67. Noorlander CW, de Graan PN, Nikkels PG, Schrama LH, Visser GH: Distribution of glutamate transporters in the human placenta. Placenta 2004;25:489-495. (Pubitemid 38701891)
68. O'Kane RL, Martinez-Lopez I, DeJoseph MR, Vina JR, Hawkins RA: Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem 1999;274:31891-31895.
69. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW: Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84.
70. Li S, Mallory M, Alford M, Tanaka S, Masliah E: Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 1997;56:901-911. (Pubitemid 27329111)
71. Tian G, Lai L, Guo H, Lin Y, Butchbach ME, Chang Y, Lin CL: Translational control of glial glutamate transporter EAAT2 expression. J Biol Chem 2007;282:1727-1737. (Pubitemid 47076686)
72. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J: Molecular mechanisms of schizophrenia. Cell Physiol Biochem 2007;20:687-702. (Pubitemid 350059714)
73. Rumbaugh JA, Li G, Rothstein J, Nath A: Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins. J Neurovirol 2007;13:168-172. (Pubitemid 46780092)
74. Pampliega O, Domercq M, Villoslada P, Sepulcre J, Rodriguez-Antiguedad A, Matute C: Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J Neuroimmunol 2008;195:194-198.
75. Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P: Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 2007;66:732-739. (Pubitemid 47344252)
76. Desilva TM, Billiards SS, Borenstein NS, Trachtenberg FL, Volpe JJ, Kinney HC, Rosenberg PA: Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in human periventricular leukomalacia. J Comp Neurol 2008;508:238-248. (Pubitemid 351562035)
77. Rakhade SN, Shah AK, Agarwal R, Yao B, Asano E, Loeb JA: Activity-dependent gene expression correlates with interictal spiking in human neocortical epilepsy. Epilepsia 2007;48 Suppl 5:86-95. (Pubitemid 47512207)
78. Rakhade SN, Loeb JA: Focal reduction of neuronal glutamate transporters in human neocortical epilepsy. Epilepsia 2008;49:226-236. (Pubitemid 351171989)
79. van Landeghem FK, Weiss T, Oehmichen M, von Deimling A: Decreased expression of glutamate transporters in astrocytes after human traumatic brain injury. J Neurotrauma 2006;23:1518-1528. (Pubitemid 46489609)
80. Boycott HE, Dallas M, Boyle JP, Pearson HA, Peers C: Hypoxia suppresses astrocyte glutamate transport independently of amyloid formation. Biochem Biophys Res Commun 2007;364:100-104. (Pubitemid 47599451)
81. Hurtado O, Pradillo JM, Fernandez-Lopez D, Morales JR, Sobrino T, Castillo J, Alborch E, Moro MA, Lizasoain I: Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke. Neurobiol Dis 2008;29:123-131. (Pubitemid 350180488)
82. Matsumoto Y, Suzuki A, Ishii G, Oshino S, Otani K, Goto K: The -181 A/C polymorphism in the excitatory amino acid transporter-2 gene promoter affects the personality trait of reward dependence in healthy subjects. Neurosci Lett 2007;427:99-102. (Pubitemid 47633791)
83. Bailey CG, Ryan RM, Thoeng AD, Ng C, King K, Vanslambrouck JM, Auray-Blais C, Vandenberg RJ, Broer S, Rasko JE: Lossof-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest 2011;121:446-453.
84. Deng X, Shibata H, Takeuchi N, Rachi S, Sakai M, Ninomiya H, Iwata N, Ozaki N, Fukumaki Y: Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2007;144:271-278. (Pubitemid 46642014)
85. Nudmamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia J Neural Transm Suppl 2007;281-285.
86. Chan H, Zwingmann C, Pannunzio M, Butterworth RF: Effects of ammonia on high affinity glutamate uptake and glutamate transporter EAAT3 expression in cultured rat cerebellar granule cells. Neurochem Int 2003;43:137-146. (Pubitemid 36292141)
87. Mangoura D, Pelletiere C, Leung S, Sakellaridis N, Wang DX: Prolactin concurrently activates src-PLD and JAK/Stat signaling pathways to induce proliferation while promoting differentiation in embryonic astrocytes. Int J Dev Neurosci 2000;18:693-704. (Pubitemid 30649692)
88. Verma A, Kambhampati S, Parmar S, Platanias LC: Jak family of kinases in cancer. Cancer Metastasis Rev 2003;22:423-434. (Pubitemid 36791897)
89. De Keersmaecker K, Cools J: Chronic myeloproliferative disorders: A tyrosine kinase tale. Leukemia 2006;20:200-205. (Pubitemid 43148653)
90. Kiss R, Sayeski PP, Keseru GM: Recent developments on JAK2 inhibitors: A patent review. Expert Opin Ther Pat 2010;20:471-495.
91. Verstovsek S: Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosis. Clin Cancer Res 2010;16:1988-1996.
92. Minciu MM, Misra H, Zagrean L: The neuroprotective effect of intranasally applied leptin against hypoxic neuronal injury. Med Hypotheses 2010;74:1036-1037.
93. Obeid M, Frank J, Medina M, Finckbone V, Bliss R, Bista B, Majmudar S, Hurst D, Strahlendorf H, Strahlendorf J: Neuroprotective effects of leptin following kainic acid-induced status epilepticus. Epilepsy Behav 2010;19:278-283.
94. Yoo JY, Won YJ, Lee JH, Kim JU, Sung IY, Hwang SJ, Kim MJ, Hong HN: Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures. J Neurosci Res 2009;87:150-163.